(Q27009157)

L. Froelich

3

1 reference

H. Soininen

5

1 reference

G. Waldemar

6

1 reference

L.-O. Wahlund

7

1 reference

B. Dubois

8

1 reference

language of work or name

1 reference

March 2014

1 reference

Journal of Internal Medicine

published in

1 reference

volume

275

1 reference

issue

3

1 reference

page(s)

204-13

1 reference

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Revising the definition of Alzheimer's disease: a new lexicon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Changes in brain function occur years before the onset of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Preliminary evidence of validity of the revised criteria for Alzheimer disease diagnosis: report of 2 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Lack of accuracy for the proposed 'Dubois criteria' in Alzheimer's disease: a validation study from the Swedish brain power initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Impaired financial abilities in mild cognitive impairment: a direct assessment approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

MCI is associated with deficits in everyday functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Arguments against the biomarker-driven diagnosis of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Early dementia diagnosis and the risk of suicide and euthanasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Early-stage Alzheimer disease represents increased suicidal risk in relation to later stages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Reaction to a dementia diagnosis in individuals with Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

What belgian neurologists and neuropsychiatrists tell their patients with Alzheimer disease and why: a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Spouse caregivers' attitudes toward obtaining a diagnosis of a dementing illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Family members favor disclosing the diagnosis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

The Clinical Dementia Rating (CDR): current version and scoring rules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Focal cortical presentations of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199

Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12199